Drug Information Association Logo

FDA Commissioner Hamburg to Discuss Collaboration at DIA’s 2013 49th Meeting

WASHINGTON — May 24, 2013

Leaders of the World’s Most Influential Drug Regulatory Agencies Share Their Views

U.S. Food and Drug Administration Commissioner Margaret Hamburg will discuss collaboration among global drug regulatory agencies at the DIA 2013 49th Annual Meeting in Boston on June 24. The session, titled Cooperation Among Regulators: Impact on Stakeholders, will explore how interagency actions and strategic communications can facilitate efforts to improve the safety and effectiveness of medical product development and access.

Hamburg will be joined by European Medicines Agency Executive Director Guido Rasi and Paul Glover, assistant deputy minister of the Health Products and Food Branch at Health Canada.

“This unique forum will highlight the collaboration of these key regulatory agencies, and how it benefits our vital work of developing and making available lifesaving therapies for patients around the world,” said Susan Cantrell, director of DIA North America.

As FDA’s top official, Hamburg is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote public health. Her participation at the DIA 2013 49th Annual Meeting will set the stage to foster collaboration and drive conversation between decision-makers and stakeholders on the development and regulation of safe and effective medical products.

What: Cooperation Among Regulators: Impact on Stakeholders at the DIA 2013 49th Annual Meeting 

Where: Boston Convention & Exhibition Center, 415 Summer St., Boston

When: 2:30–4 PM Monday, June 24, 2013







ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.